Cellular Health Screening Market Report 2025 (Global Edition)

Global Cellular Health Screening Market Report 2025 Market Size Split by Type (Single-Test Panels, Multi-Test Panels), by Sample (Blood, Other samples), by Sample Collection (At-Home, In Office, Other...

Cellular Health Screening Market Report Description

We have various report editions of Cellular Health Screening Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Cellular Health Screening Market Insights Video

Competitive Landscape of the Cellular Health Screening Market

The competitive landscape of the cellular health screening market is characterized by a mix of established players and emerging startups, primarily based in the United States and Europe. Key players include Bloom Diagnostics, Guardant Health, Exact Sciences Corporation, and Foundation Medicine Inc. Intense competition drives innovation and product differentiation, with companies focusing on technological advancements, strategic collaborations, and market expansion initiatives to gain a competitive edge. Regulatory compliance, quality assurance, and customer satisfaction are critical factors shaping competitive dynamics in the market.

May 2022: QIAGEN NV introduced its latest product, the QIAstat Dx Rise, along with improved panels. The QIAstat Dx Rise system, along with its test cartridges, provides a closed system ensuring hands-off sample preparation and processing.

(Source: https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2024/QIAGEN-receives-FDA-clearance-for-QIAstat-Dx-respiratory-syndromic-testing-panel-for-fast-and-accurate-results/default.aspx )

Top Companies Market Share in Cellular Health Screening Industry: (In no particular order of Rank)

• Bloom Diagnostics (Switzerland)
• Guardant Health (United States)
• Exact Sciences Corporation (United States)
• Foundation Medicine Inc. (United States)
• PathAI (United States)
• Invitae Corporation (United States)
• Freenome Holdings Inc. (United States)
• 10x Genomics Inc. (United States)
• Veracyte Inc. (United States)
• Pacific Biosciences of California Inc. (United States)
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Cellular Health Screening Market

Which Region Dominates the Cellular Health Screening Market in 2024?

According to Cognitive Market Research, North America dominates the cellular health screening market due to several factors. The region benefits from robust healthcare infrastructure, advanced technological capabilities, and high healthcare expenditure. Additionally, supportive regulatory frameworks and reimbursement policies facilitate market growth. Moreover, a large population base, rising prevalence of chronic diseases, and increasing awareness about preventive healthcare drive demand for cellular health screening services in North America. These factors collectively contribute to the region's significant market share in the cellular health screening industry.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region exhibits the fastest compound annual growth rate (CAGR) in the cellular health screening market due to several factors. These include increasing healthcare spending, rising prevalence of chronic diseases, and improving healthcare infrastructure. Additionally, expanding access to advanced diagnostic technologies, growing awareness about preventive healthcare, and supportive government initiatives contribute to market growth. Moreover, the large population base in the region presents substantial market opportunities, driving the adoption of cellular health screening services at a rapid pace.

 

The current report Scope analyzes Cellular Health Screening Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Cellular Health Screening

According to Cognitive Market Research, the global Cellular Health Screening Market size was estimated at USD 2516.20 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1006.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Cellular Health Screening Market with a market size of USD 794.11 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. The demand is amplified by the nation's rising prevalence of chronic diseases.
• The Canada Cellular Health Screening Market had a market share of USD 120.78 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. This is due to robust healthcare infrastructure.
• The Mexico Cellular Health Screening Market is projected to witness growth at a CAGR of 8.2% during the forecast period with a market size of USD 91.59 million in 2024.

Europe Cellular Health Screening

According to Cognitive Market Research, the global Cellular Health Screening Market size was estimated at USD 2516.20 Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD 754.86 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.

• The United Kingdom Cellular Health Screening Market had a market share of USD 126.82 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. In the UK, Automated Storage And Retrieval Systems sales witness an upswing due to region's aging population.
• The France Cellular Health Screening Market is projected to witness growth at a CAGR of 7.2% during the forecast period with a market size of USD 69.45 million in 2024.
• According to Cognitive Market Research, the Germany Cellular Health Screening Market size was valued at USD 149.46 million in 2024 and is projected to grow at a CAGR of 8.2% during the forecast period. In Germany, Automated Storage And Retrieval Systems sales surge due to rising awareness about preventive healthcare.
• The Italy Cellular Health Screening Market is projected to witness growth at a CAGR of 7.4% during the forecast period with a market size of USD 64.92 million in 2024.
• The Russia Cellular Health Screening Market is projected to witness growth at a CAGR of 7.0% during the forecast period with a market size of USD 117.00 million in 2024.
• The Spain Cellular Health Screening Market is projected to witness growth at a CAGR of 7.1% during the forecast period with a market size of USD 61.90 million in 2024
• The Luxembourg Cellular Health Screening Market is projected to witness growth at a CAGR of 8.1% during the forecast period with a market size of USD 23.40 million in 2024.
• The Portugal Cellular Health Screening Market is projected to witness growth at a CAGR of 7.8% during the forecast period with a market size of USD 15.85 million in 2024.
• The Greece Cellular Health Screening Market is projected to witness growth at a CAGR of 6.8% during the forecast period with a market size of USD 8.3 million in 2024.
• Rest of Europe Cellular Health Screening Market is projected to witness growth at a CAGR of 6.7% during the forecast period with a market size of USD 117.00 million in 2024.

Asia Pacific Cellular Health Screening

According to Cognitive Market Research, the global Cellular Health Screening Market size was estimated at USD 2516.20 Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 578.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Cellular Health Screening Market size was valued at USD 260.43 million in 2024 and is projected to grow at a CAGR of 11.0% during the forecast period. Automated Storage And Retrieval Systems sales surge in China due to increasing healthcare investments.
• The Japan Cellular Health Screening Market is projected to witness growth at a CAGR of 10.0% during the forecast period with a market size of USD 79.86 million in 2024.
• The India Cellular Health Screening Market had a market share of USD 69.45 million in 2024 and is projected to grow at a CAGR of 13.3% during the forecast period. This is due to rising awareness about preventive healthcare.
• The South Korea Cellular Health Screening Market is projected to witness growth at a CAGR of 10.6% during the forecast period with a market size of USD 57.87 million in 2024.
• The Australia Cellular Health Screening Market is projected to witness growth at a CAGR of 11.2% during the forecast period with a market size of USD 30.09 million in 2024.
• The South East Asia Cellular Health Screening Market is projected to witness growth at a CAGR of 12.5% during the forecast period with a market size of USD 39.93 million in 2024.
• The Rest of Asia Pacific Cellular Health Screening Market is projected to witness growth at a CAGR of 11.3% during the forecast period with a market size of USD 41.09 million in 2024.

South America Cellular Health Screening

According to Cognitive Market Research, the global Cellular Health Screening Market size was estimated at USD 2516.20 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 125.81 million in 2024 and will grow

• According to Cognitive Market Research, the Brazil Cellular Health Screening Market size was valued at USD 53.85 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. Automated Storage And Retrieval Systems sales flourish in Brazil due to region's aging population.
• Argentina Cellular Health Screening Market had a market share of USD 21.14 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. This is due to increasing healthcare expenditure.
• Colombia Cellular Health Screening Market is projected to witness growth at a CAGR of 8.7% during the forecast period with a market size of USD 11.20 million in 2024.
• Peru Cellular Health Screening Market is projected to witness growth at a CAGR of 9.1% during the forecast period with a market size of USD 10.32 million in 2024.
• Chile Cellular Health Screening Market is projected to witness growth at a CAGR of 9.2% during the forecast period with a market size of USD 9.06 million in 2024.
• The Rest of Latin America Cellular Health Screening Market is projected to witness growth at a CAGR of 8.0% during the forecast period with a market size of USD 20.26 million in 2024.

at a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.

Middle East Cellular Health Screening

According to Cognitive Market Research, the global Cellular Health Screening Market size was estimated at USD 2516.20 Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 50.32 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.

• The GCC Countries Cellular Health Screening Market is projected to witness growth at a CAGR of 8.5% during the forecast period with a market size of USD 21.54 million in 2024. Automated Storage And Retrieval Systems sales flourish due to region's growing population
• The Egypt Cellular Health Screening Market is projected to witness growth at a CAGR of 8.1% during the forecast period with a market size of USD 5.28 million in 2024.
• The South Africa Cellular Health Screening Market is projected to witness growth at a CAGR of 8.7% during the forecast period with a market size of USD 7.95 million in 2024. Automated Storage And Retrieval Systems sales flourish in the South Africa due to rising prevalence of chronic diseases.
• The Turkey Cellular Health Screening Market is projected to witness growth at a CAGR of 7.2% during the forecast period with a market size of USD 4.33 million in 2024.
• The Nigeria Cellular Health Screening Market is projected to witness growth at a CAGR of 6.8% during the forecast period with a market size of USD 5.28 million in 2024.
• The Rest of MEA Cellular Health Screening Market is projected to witness growth at a CAGR of 6.7% during the forecast period with a market size of USD 5.94 million in 2024.

Cellular Health Screening Market Analysis

Cellular Health Screening Market Type Segment Analysis

According to Cognitive Market Research, Single-Test Panels stands out as the dominating category. Single-test panels have secured the largest market share in the cellular health screening market due to several reasons. These panels offer simplicity, convenience, and cost-effectiveness by focusing on specific biomarkers or health indicators in a single test. Moreover, they provide targeted insights into particular health conditions, enabling efficient screening and diagnosis. Additionally, single-test panels are favored by healthcare providers and patients for their ease of use, quick turnaround time, and clear interpretation of results, driving their widespread adoption.

Multi-test panels are experiencing the highest compound annual growth rate (CAGR) in the cellular health screening market due to their comprehensive nature and ability to assess multiple biomarkers simultaneously. These panels offer a holistic view of an individual's health status, allowing for early detection of various diseases and conditions. Additionally, they provide greater diagnostic accuracy and clinical utility compared to single-test panels. The growing emphasis on personalized medicine and preventive healthcare further drives the demand for multi-test panels, fueling their rapid growth.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Cellular Health Screening Industry. Request a Free Sample PDF!

Cellular Health Screening Market Sample Type Segment Analysis

According to Cognitive Market Research, the dominating category is Blood. Blood sample type has secured the largest market share in the cellular health screening market for several reasons. Blood samples offer accessibility, ease of collection, and widespread availability in clinical settings. Additionally, blood-based tests provide comprehensive insights into cellular health and biomarker levels, enabling the detection of a wide range of health conditions. Moreover, advancements in blood-based screening technologies and the growing adoption of point-of-care testing further drive the dominance of blood sample type in the market.

The "Other samples" sample type, including saliva, urine, and tissue samples, is experiencing the highest compound annual growth rate (CAGR) in the cellular health screening market due to several factors. These sample types offer non-invasive or minimally invasive collection methods, enhancing patient comfort and compliance. Moreover, advancements in analytical techniques enable comprehensive analysis of biomarkers from diverse sample types, expanding the scope of cellular health screening. Additionally, the growing research focus on alternative sample types and their clinical utility drives their increasing adoption, fueling market growth.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Cellular Health Screening Sample Collection Segment Analysis

According to Cognitive Market Research, the dominating category is At-Home. At-home sample collection sites have captured the largest market share in the cellular health screening market due to their convenience, accessibility, and growing consumer preference for remote healthcare services. These sites offer individuals the flexibility to collect samples from the comfort of their homes, eliminating the need for clinic visits and reducing logistical barriers. Moreover, advancements in sample collection kits and logistics ensure sample integrity and accuracy, further driving the popularity of at-home sample collection sites in the market.

In-office sample collection sites are experiencing the highest compound annual growth rate (CAGR) in the cellular health screening market due to several factors. These sites offer convenience, efficiency, and immediate access to healthcare professionals, facilitating streamlined sample collection and testing processes. Moreover, in-office sample collection ensures sample quality and integrity, minimizing pre-analytical errors and reducing turnaround times for results. Additionally, the growing demand for point-of-care testing and personalized healthcare services drives the adoption of in-office sample collection sites, fueling their rapid growth.

• At-Home
• In Office
• Other

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion